
World Pneumonia Day 2023: the rising global threat of pneumonia and what we must do about it
World Pneumonia Day 2023: the rising global threat of pneumonia and what we must do about it
Catia Cilloniz, Charles Dela Cruz, Walter H. Curioso, Cesar Herrera Vidal, Pneumo-Strategy
European Respiratory Journal 2023 62: 2301672; DOI: 10.1183/13993003.01672-2023
Extract
Pneumonia is an infection of the lungs that causes inflammation [1]. A large variety of microorganisms can cause pneumonia, including bacteria, viruses or fungi [1]. Pneumonia is often classified according to the site of acquisition into community-acquired pneumonia (CAP) or hospital-acquired pneumonia (HAP) [1]. Considered as the leading infectious cause of death globally, pneumonia is associated with high morbidity and short- and long-term mortality in all age groups in the world (figure 1) [1].
Tweetable abstract @ERSpublications
On 12 November 2023 we mark World Pneumonia Day. The day is an opportunity to raise awareness, advocate for and give visibility to pneumonia, the leading infectious cause of death across all age groups globally https://bit.ly/3QjSJuf
Footnotes
-
Members of the Expert Scientific Group on Pneumonia: Pneumo-Strategy are as follows. Catia Cilloniz: University of Barcelona, Spain, Coordinator of Pneumo-Strategy, and European Respiratory Society (ERS); Anita Simonds: Sleep and Ventilation Unit, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, London, UK, and ERS; Kjeld Hansen: Copenhagen Business School, Frederiksberg, Copenhagen, Denmark, Kristiania University College, Oslo, Norway, and European Lung Foundation (ELF); Josep Alouch: Department of Medicine, University of Nairobi, Kenya, and Pan African Thoracic Society (PATS); Heather Zar: Department of Paediatrics and Child Health and SA Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa, and PATS; Yoichi Nakanishi: Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Kitakyushu City Hospital Organisation, Fukuoka, Japan, and Asian Pacific Society of Respirology (APSR); Stephanie Levine: University of Texas Health San Antonio and the South Texas Veterans Healthcare System, San Antonio, TX, USA, and College of Chest Physicians (Chest); Mark Cohen: Pulmonary and Intensive Care Unit, Centro Medico Hospital, Guatemala, Guatemala, and Forum International of Respiratory Societies (FIRS) and Latin American Thorax Association (ALAT); Charles Dela Cruz: Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA, and American Thoracic Society (ATS); Scott E. Evans: Department of Pulmonary Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA, and ATS; Maurizio Sanguinetti: Institute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy, and European Society of Clinical Microbiology and Infectious Disease (ESCMID); Jordi Vila: Microbiology Department, Hospital Clinic of Barcelona, Spain, and Spanish Society of Infectious Diseases and Microbiology (SEIMC); Jesús DÃez Manglano: Department of Internal Medicine, Hospital Royo Villanova, Zaragoza, Spain, and Spanish Society of Internal Medicine (SEMI); Ricard Ferrer: Intensive Care Department, Hospital Universitari Vall d'Hebron, Barcelona, and Spanish Society of Intensive and Critical Medicine and Coronary Units (SEMICYUC); Lucio Criado: Clinical coordinator of the Sanatorio de la Providencia CABA, Argentina, and Argentine Society of Medicine (SAM); José Polo GarcÃa: Casar de Cáceres Health Centre, Cáceres, Spain, and Spanish Society of Primary Care Physicians (SEMERGEN); Zaira Correcher: General University Hospital and CS Almassora, Castello, Spain, and SEMERGEN; Diana Rodriguez-Hurtado: Department of Medicine, National Hospital “Arzobispo Loayza”, Peruvian University “Cayetano Heredia”, Lima, Peru, and Peruvian Society of Internal Medicine (SPMI); Carmen Terrazas: Intensive Care Unit, Sabogal Hospital, Lima, Peru, and Peruvian Society of Intensive Medicine (SOPEMI); Carmen Muñoz-Almagro: Instituto de Recerca Pediatrica, Hospital Sant Joan de Déu, Barcelona, Spain, and Catalan Society of Infectious Diseases and Clinical Microbiology (SCMIMC); Carolina Garcia-Vidal: Infectious Disease Department, Hospital Clinic of Barcelona, Spain, and ESCMID; Zeina Aoun: Department of Pulmonary and Critical Care, Hôtel Dieu de France University Hospital, Beirut, Lebanon, and Lebanese Pulmonary Society (LPS); Juan Manuel Péricas: Liver Unit, Vall d'Hebron Institut de Recerca, Vall d'Hebron Barcelona Hospital, Barcelona, Spain; Israel Amirav: Paediatric Department, University of Alberta, Edmonton, Canada, Paediatric Pulmonology Unit, Ichilov Tel-Aviv Medical Centre, Tel-Aviv, Israel, and Israeli Association of Paediatric Pulmonology (IAPP).
-
Conflict of interest: All authors declare that they have no conflicts of interest.
- Received September 30, 2023.
- Accepted October 28, 2023.
- Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org